Phase III: 8 molecules
Phase II: 9 molecules
Phase I: 32 molecules
The compounds and their uses mentioned on this website are investigational and have not been approved by the US Food and Drug Administration. Efficacy and safety have not been established. The information presented should not be construed as a recommendation for use. The relevance of findings in preclinical studies to humans is currently being evaluated.
aDeveloped in collaboration with Array BioPharma. bDeveloped in collaboration with Seattle Genetics. cDeveloped in collaboration with Exelixis. dJoint project with AbbVie. eDeveloped in collaboration with Chugai. fIgnyta Inc acquisition. gTensha acquisition. hDeveloped in collaboration with BioNTech.
- Roche first-quarter results 2018 presentation. www.roche.com/dam/jcr:6f4ad9a6-3ece-4184-aff4-ea6cd4a4b7ac/en/irp180426.pdf. Accessed April 26, 2018.
- US National Institutes of Health.
ClinicalTrials.gov. https://clinicaltrials.gov. Accessed May